Pharma Journalist -

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and ShapeTX, the programmable medicine company using AI and RNA to end genetic diseases, announce a multi-target collaboration to develop…
Read More...

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announces an antibody evaluation, option and license agreement with Myricx Bio (‘Myricx’), a UK biotech company focusing on the discovery…
Read More...

Apollo Therapeutics, a portfolio biopharmaceutical company focused on translating fundamental medical research into medicines through a hub-and-spoke approach, today announces the close…
Read More...

The Broad Institute of MIT and Harvard announced a new research alliance with Novo Nordisk aimed at addressing critical unmet clinical needs in diabetes and cardiometabolic diseases.…
Read More...

TC BioPharm (Holdings) PLC, a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, is proud to announce it has entered into a…
Read More...

Veracyte, Inc. and Gustave Roussy announced today that they have entered into a collaboration to bring together their respective capabilities to provide novel insights into the…
Read More...

Mirum Pharmaceuticals, Inc. and Travere Therapeutics, Inc. announced the completion of Mirum’s previously announced acquisition of Travere’s bile acid product portfolio that includes…
Read More...

Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immunology-based therapies, announced that it has entered…
Read More...

AstraZeneca’s Calquence (acalabrutinib), a next generation, selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in China for the treatment of adult patients with…
Read More...

GSK plc announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has accepted for review a supplementary new drug application (sJNDA) for Nucala (mepolizumab), a…
Read More...